Preterm Birth Drug Pulled From Market Over Lack of Effectiveness
WEDNESDAY, March 8, 2023 (HealthDay News) — Pregnant women will no longer have any drug to prevent preterm birth after the maker of the only available treatment announced Tuesday that it will withdraw its product, Makena, from the market.Covis Pharma…
Learn MoreOpioids Cause Half of All Poisonings in U.S. Kids Age 5 and Younger
WEDNESDAY, March 8, 2023 (HealthDay News) — Opioids pose the greatest poison risk to children in the United States, accounting for more than half of poisoning deaths in infants and toddlers, a new study reports.About 52% of poisoning deaths of childr…
Learn MoreIs Your Tap Water Too Hot? Scalding Burns Send Thousands to ER Each Year
WEDNESDAY, March 8, 2023 (HealthDay News) — A water heater set to 120 degrees Fahrenheit can release water from the tap hot enough to cause a second-degree burn in about nine minutes. Turned up to 130 degrees, that injury happens in just 25 seconds. …
Learn MoreWomen Have Poorer Survival Than Men After Bypass Surgery
WEDNESDAY, March 8, 2023 (HealthDay News) — Women are more likely than men to die after coronary artery bypass surgery, according to a large new study.Researchers still don’t understand why women have these poorer outcomes.“This should be a ‘wake-up …
Learn MoreLos jóvenes de EE. UU. se enfrentan a unas tasas crecientes de obesidad, hipertensión y diabetes
LUNES, 6 de marzo de 2023 (HealthDay News) — Los adultos jóvenes en Estados Unidos soportan una creciente carga de factores de riesgo de la enfermedad cardiaca, lo que hace que sea más probable que sufran un ataque cardiaco o un accidente cerebrovasc…
Learn MoreUn panel de la FDA reevaluará el mérito de un descongestionante que muchos califican de inútil
LUNES, 6 de marzo de 2023 (HealthDay News) — Hace años que los consumidores utilizan un descongestionante oral de venta libre llamado fenilefrina, pero quizá esta situación no continúe mucho tiempo.La Administración de Alimentos y Medicamentos (FDA) …
Learn MoreMotavizumab, Nirsevimab, Palivizumab Beneficial for RSV Prevention
TUESDAY, March 7, 2023 (HealthDay News) — Significant benefits are seen with motavizumab, nirsevimab, and palivizumab for prevention of respiratory syncytial virus (RSV) in infants and children, according to a review published online Feb. 17 in JAMA …
Learn MoreVerapamil Partially Preserves C-Peptide Secretion in Children With T1DM
TUESDAY, March 7, 2023 (HealthDay News) — Verapamil partially preserves stimulated C-peptide secretion at 52 weeks after diagnosis among children with newly diagnosed type 1 diabetes, according to a study published online Feb. 24 in the Journal of th…
Learn MoreGenetic Susceptibility to Ovarian Cancer Does Not Modify Protective Effect of Aspirin
TUESDAY, March 7, 2023 (HealthDay News) — Genetic susceptibility to ovarian cancer does not modify the protective effect of frequent aspirin use on ovarian cancer risk, according to a study published online Feb. 24 in JAMA Network Open.Lauren M. Hurw…
Learn MoreHow Soon Can You Resume Tennis, Golf After Shoulder Surgery?
TUESDAY, March 7, 2023 (HealthDay News) — Returning to golf, tennis or pickleball after shoulder replacement surgery shouldn’t be too hard.Healing does take time, but within a few months most people can get back to play at their pre-surgery level wit…
Learn More